Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

54.70
-0.9200-1.65%
Volume:855.12K
Turnover:46.35M
Market Cap:4.36B
PE:-14.61
High:55.65
Open:55.28
Low:53.14
Close:55.62
Loading ...

Chief Development Officer Catriona Yale Reports Disposal of Common Shares in Akero Therapeutics Inc

Reuters
·
13 Jun

Senior VP Patrick Lamy Reports Disposal of Common Shares in Akero Therapeutics Inc

Reuters
·
13 Jun

Timothy Rolph, Chief Scientific Officer, Reports Disposal of Akero Therapeutics Common Shares

Reuters
·
10 Jun

Akero Therapeutics rumor highlighted in Betaville blog

TIPRANKS
·
09 Jun

Senior VP Patrick Lamy Reports Disposal of Common Shares of Akero Therapeutics Inc

Reuters
·
05 Jun

Akero Therapeutics Inc. Concluded Annual Stockholders Meeting

Reuters
·
05 Jun

Buy Rating for Akero Therapeutics Driven by EFX’s Promising Position in MASH Treatment and Market Potential

TIPRANKS
·
28 May

Akero Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
27 May

Akero Therapeutics price target raised to $64 from $63 at BofA

TIPRANKS
·
27 May

Akero Therapeutics Inc : Bofa Global Research Raises Price Objective to $64 From $63

THOMSON REUTERS
·
27 May

Patrick Lamy, Senior VP at Akero Therapeutics Inc., Reports Disposal of Common Shares

Reuters
·
24 May

Akero Therapeutics up 16% after Street Insider report on sale being considered

TIPRANKS
·
21 May

Akero Therapeutics exploring potential sale after approach, Street Insider says

TIPRANKS
·
21 May

Chief Development Officer Catriona Yale Reports Disposal of Common Shares in Akero Therapeutics Inc

Reuters
·
20 May

Analysts Are Bullish on Top Healthcare Stocks: Akero Therapeutics (AKRO), BioCardia (BCDA)

TIPRANKS
·
15 May

Akero Therapeutics (AKRO) Receives a Buy from Evercore ISI

TIPRANKS
·
14 May

Andrew Cheng, President and CEO, Reports Disposal of Common Shares in Akero Therapeutics Inc

Reuters
·
14 May

BRIEF-Pfizer Dissolves Share Stake In Akero Therapeutics

Reuters
·
14 May

Pfizer Dissolves Share Stake in Akero Therapeutics- SEC Filing

THOMSON REUTERS
·
14 May

Akero Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
14 May